Lanford RE et al. |
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. |
2003 |
Virology |
pmid:12832204
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Mahalingam R et al. |
Simian varicella virus reactivation in cynomolgus monkeys. |
2007 |
Virology |
pmid:17651776
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
MistrÃková J et al. |
Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). |
1999 |
Viral Immunol. |
pmid:10532652
|
Gambarino S et al. |
Human Cytomegalovirus Impact on mir-146a Expression Levels in Kidney Transplant Patients. |
2016 |
Viral Immunol. |
pmid:27077822
|
Shen ZY et al. |
Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo. |
2012 |
Viral Immunol. |
pmid:22946668
|
Mortola E et al. |
The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus. |
1998 |
Vet. Res. Commun. |
pmid:10066129
|
Tanaka Y et al. |
Suppression of feline coronavirus replication in vitro by cyclosporin A. |
2012 |
Vet. Res. |
pmid:22546085
|
Kano R et al. |
Treatment of sterile panniculitis in a dog. |
2004 |
Vet. Rec. |
pmid:15134169
|
Ofri R et al. |
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. |
2009 |
Vet. J. |
pmid:17950639
|
Sestak K et al. |
Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. |
2000 |
Vet. Immunol. Immunopathol. |
pmid:11137126
|
Marsella R et al. |
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. |
2004 |
Vet. Dermatol. |
pmid:15500481
|
Mauldin EA et al. |
Proliferative and necrotizing otitis externa in four cats. |
2007 |
Vet. Dermatol. |
pmid:17845627
|
Banovic F et al. |
Tacrolimus therapy for dermal arteritis of the nasal philtrum refractory to surgery and anti-inflammatory therapy (doxycycline/niacinamide and topical fluocinolone) in a dog. |
2018 |
Vet. Dermatol. |
pmid:28990239
|
Hilton H et al. |
Evaluation of four topical preparations for the treatment of cannon hyperkeratosis in a horse. |
2008 |
Vet. Dermatol. |
pmid:19055613
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Banovic F et al. |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus. |
2017 |
Vet. Dermatol. |
pmid:28439997
|
Rosenkrantz WS |
Pemphigus: current therapy. |
2004 |
Vet. Dermatol. |
pmid:15030557
|
Olivry T et al. |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. |
2010 |
Vet. Dermatol. |
pmid:20456716
|
Marsella R et al. |
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs. |
2004 |
Vet. Dermatol. |
pmid:15305928
|
Lehner GM and Linek M |
A case of vesicular cutaneous lupus erythematosus in a Border collie successfully treated with topical tacrolimus and nicotinamide-tetracycline. |
2013 |
Vet. Dermatol. |
pmid:24118370
|
Kelley LS et al. |
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis. |
2010 |
Vet. Dermatol. |
pmid:20609208
|
Bensignor E and Olivry T |
Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. |
2005 |
Vet. Dermatol. |
pmid:15725106
|
Scholz FM et al. |
Focal metatarsal fistulae syndrome affecting a greyhound dog successfully treated with topical 0.1% tacrolimus ointment. |
2015 |
Vet. Dermatol. |
pmid:26216245
|
Nell B et al. |
The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study. |
2005 Jan-Feb |
Vet Ophthalmol |
pmid:15644099
|
Berdoulay A et al. |
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. |
2005 Jul-Aug |
Vet Ophthalmol |
pmid:16008701
|
Hafizi S et al. |
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. |
2004 May-Jun |
Vascul. Pharmacol. |
pmid:15607500
|
Dissemond J et al. |
Successful treatment of stasis dermatitis with topical tacrolimus. |
2004 |
VASA |
pmid:15623206
|
Woodward RS et al. |
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. |
2011 |
Value Health |
pmid:21315636
|
Christ B et al. |
Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. |
2001 |
Urology |
pmid:11597545
|
Harmon JD et al. |
Stuttering priapism in a liver transplant patient with toxic levels of fk506. |
1999 |
Urology |
pmid:10754131
|
Chkhotua AB et al. |
Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. |
2003 |
Urology |
pmid:14665344
|
Ebert AK et al. |
[Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview]. |
2007 |
Urologe A |
pmid:17994212
|
|
[Tacrolimus--a new perspective in kidney transplantation]. |
1996 |
Urologe A |
pmid:9022401
|
Nomura T et al. |
Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells. |
2002 |
Urol. Res. |
pmid:12086014
|
Hwang MT and Goldfarb DS |
Uric acid stones following hepatic transplantation. |
2004 |
Urol. Res. |
pmid:15565437
|
Veroux P et al. |
Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases. |
2003 |
Urol. Int. |
pmid:14646448
|
Pichler R et al. |
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. |
2014 |
Urol. Int. |
pmid:25115614
|
Naderi GH et al. |
Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections. |
2009 |
Urol J |
pmid:19241339
|
Freire A et al. |
Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays. |
2008 |
Ups. J. Med. Sci. |
pmid:18521804
|
Präst I et al. |
Nerve cells in transplanted pancreatic islets: no effects of cyclosporin or tacrolimus on immediate neuronal survival. |
2001 |
Ups. J. Med. Sci. |
pmid:11888070
|
Valesky EM et al. |
[Postoperative pyoderma gangrenosum of Cullen]. |
2007 |
Unfallchirurg |
pmid:17786400
|
Deleuran M et al. |
[Topical immune modulation and risk of cancer]. |
2009 |
Ugeskr. Laeg. |
pmid:19732533
|
Rosenzweig M |
[Prescription of topical immunomodulators]. |
2009 |
Ugeskr. Laeg. |
pmid:19732534
|
Thestrup-Pedersen K and Thomsen TF |
[Creams used in the treatment of children can cause cancer]. |
2005 |
Ugeskr. Laeg. |
pmid:15832731
|
Tusgaard Petersen B et al. |
[Family occurrence of steroid-sensitive idiopathic nephrotic syndrome]. |
2012 |
Ugeskr. Laeg. |
pmid:23153469
|
Mørtz CG and Deleuran MS |
[A case of childhood granulomatous perioral dermatitis (CGPD) in a three year old boy from Madagascar]. |
2008 |
Ugeskr. Laeg. |
pmid:18252166
|
Tümgör G et al. |
Fatty liver due to high levels of serum tacrolimus after liver transplantation. |
2007 Apr-Jun |
Turk. J. Pediatr. |
pmid:17907528
|
Ismailoglu O et al. |
Topical application of tacrolimus prevents epidural fibrosis in a rat postlaminectomy model: histopathological and ultrastructural analysis. |
2011 |
Turk Neurosurg |
pmid:22194127
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Shin BH et al. |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. |
2014 |
Transplantation |
pmid:24342979
|
Yoon SH et al. |
CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). |
2013 |
Transplantation |
pmid:23364483
|
Neuhaus P et al. |
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. |
1995 |
Transplantation |
pmid:7530868
|
Koneru B et al. |
Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? |
1997 |
Transplantation |
pmid:9197350
|
Lawsin L and Light JA |
Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. |
2003 |
Transplantation |
pmid:12544890
|
Furukawa H et al. |
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. |
2000 |
Transplantation |
pmid:10670633
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Toso C et al. |
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. |
2003 |
Transplantation |
pmid:14557767
|
Vu MD et al. |
Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. |
2003 |
Transplantation |
pmid:12792496
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Khanna AK |
Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. |
2000 |
Transplantation |
pmid:10972232
|
Butani L et al. |
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. |
2003 |
Transplantation |
pmid:12883183
|
Marcén R et al. |
Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. |
2006 |
Transplantation |
pmid:16570003
|
Sood P et al. |
Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. |
2012 |
Transplantation |
pmid:23018881
|
Alonso-Arias R et al. |
CD127(low) expression in CD4+CD25(high) T cells as immune biomarker of renal function in transplant patients. |
2009 |
Transplantation |
pmid:19667968
|
Galliford J et al. |
ABO incompatible living renal transplantation with a steroid sparing protocol. |
2008 |
Transplantation |
pmid:18852653
|
Egawa H et al. |
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. |
1995 |
Transplantation |
pmid:7533958
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Herlenius G et al. |
Chronic kidney disease--a common and serious complication after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622286
|
Ceulemans LJ et al. |
Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. |
2015 |
Transplantation |
pmid:25695790
|
Thorp M et al. |
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. |
2000 |
Transplantation |
pmid:10762229
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
Jun KR et al. |
Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. |
2009 |
Transplantation |
pmid:19384171
|
Ji E et al. |
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
2012 |
Transplantation |
pmid:22992768
|
Fukushima D et al. |
Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. |
2015 |
Transplantation |
pmid:24846306
|
Egli A et al. |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. |
2013 |
Transplantation |
pmid:23274966
|
Wennberg L et al. |
The efficacy of CD40 ligand blockade in discordant pig-to-rat islet xenotransplantation is correlated with an immunosuppressive effect of immunoglobulin. |
2005 |
Transplantation |
pmid:15665763
|
Gruessner RW et al. |
Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. |
1998 |
Transplantation |
pmid:9701258
|
Thai NL et al. |
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. |
2006 |
Transplantation |
pmid:17198247
|
Konrad T et al. |
Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. |
2000 |
Transplantation |
pmid:10852599
|
Aisa Y et al. |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. |
2005 |
Transplantation |
pmid:16278584
|
Tanaka J et al. |
The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells. |
2005 |
Transplantation |
pmid:16378079
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|
Wang HD et al. |
Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. |
2018 |
Transplantation |
pmid:29298238
|
Dharancy S et al. |
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. |
2007 |
Transplantation |
pmid:17460561
|